WebNov 24, 2015 · Lurasidone for bipolar depression. In 2009, Sunovion made the decision to develop lurasidone for the treatment of bipolar depression. As summarized in the next section, several lines of evidence suggested that lurasidone might have utility in alleviating symptoms of depression, including evidence related to its receptor-binding profile, … WebLurasidone is a drug in the benzisothiazole class approved by the US Food and Drug Administration in June 2013 for the acute treatment of bipolar depression. Its pharmacological profile features high-affinity antagonism at D 2, 5-HT 2A, and 5-HT 7 receptors; moderate-affinity antagonism at α 2C -adrenergic receptors; low- to very low …
國泰藥訊 11007 (73) 新藥介紹:Lurasidone (Latuda - cgh.org.tw
WebApr 15, 2024 · Latuda, the brand name for lurasidone, is an atypical antipsychotic that doctors may prescribe to treat bipolar depression. You may want to consider discussing its risks and benefits with... WebJan 1, 2016 · Lurasidone, an atypical antipsychotic agent, is approved for the treatment of schizophrenia in the United States and several other countries and as monotherapy or adjunctive therapy with lithium or valproate for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression) in the United States and Canada. first pop figure ever made
Lurasidone (Latuda) NAMI: National Alliance on Mental Illness
WebIntroduction: Lurasidone has been approved in the United States as a monotherapy and adjunct for acute bipolar I depression, as well as an antipsychotic for patients with … WebBJPsych Bulletin: “Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression.” Therapeutics and Clinical risk Management : “Clinical potential of ... WebFeb 14, 2024 · Adjunctive treatment with lithium or valproate in patients with major depressive episodes associated with bipolar I disorder (bipolar depression) Usual … first pontiac trans am